The work entitled “Ligustroside derived from Ligustrum japonicum inhibits melanogenesis via blocking the MAPK and PKA/CREB signaling pathways” was published on Asian Pacific Journal of ...

NETO2 is suggested as a potential therapeutic target for melanoma, highlighting its role in facilitating melanoma progression through the CaMKII/CREB signaling pathway.

NETO2 is suggested as a potential therapeutic target for melanoma, highlighting its role in facilitating melanoma progression through the CaMKII/CREB signaling pathway.